CompuGroup Medical SE & Co. KGaA header image

CompuGroup Medical SE & Co. KGaA

COPA

Equity

ISIN US20481P1003 / Valor 18229557

Deutsche Boerse AG (2024-11-22)
EUR 14.00%

CompuGroup Medical SE & Co. KGaA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

CompuGroup Medical SE & Co. KGaA is a company that specializes in developing software solutions to streamline and enhance the medical and administrative processes of healthcare providers. Their software enables electronic communication with patients, ultimately improving efficiency and patient care within the healthcare industry. With a focus on innovation and technology, CompuGroup Medical aims to provide cutting-edge solutions to meet the evolving needs of healthcare professionals and patients alike.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (23.05.2024):

Revenue Overview

In the first quarter of 2024, CompuGroup Medical SE & Co. KGaA reported a slight decline in revenue by 2% year-over-year, primarily due to one-time effects in the telematics infrastructure. However, when adjusted for the effects from the TI connector exchange, the organic revenue growth was positive at 3%. Recurring revenues increased by 7% to EUR 213 million, accounting for 75% of the total revenue.

Earnings Performance

CompuGroup Medical SE & Co. KGaA's adjusted EBITDA for the first quarter of 2024 rose by 1% to EUR 61 million. The adjusted earnings per share also increased to EUR 0.47, supported by the divestiture of the company's business activities in Turkey. The free cash flow for the first three months stood at EUR 59 million, and the debt ratio was reduced from 2.8 times the adjusted EBITDA of the last 12 months as of March 2023 to 2.6 times.

AIS Segment Performance

The AIS segment of CompuGroup Medical SE & Co. KGaA, which now includes the former CHS segment, saw a decrease in revenue to EUR 172 million in the first quarter of 2024, down 6% from the previous year. This decline was due to one-time effects related to the exchange of connectors in the telematics infrastructure in the first quarter of 2023. Adjusted for these effects, organic revenue grew by 3%. Recurring revenues in the AIS segment increased by 5%, representing 76% of the segment's revenues.

HIS Segment Growth

The HIS segment of CompuGroup Medical SE & Co. KGaA experienced a revenue increase of 7% to EUR 78 million in the first quarter of 2024. Organic revenue growth was 6%, mainly driven by revenues from the ongoing realization of projects related to the Hospital Future Act. Recurring revenues in this segment grew by 11% to EUR 57 million, accounting for 73% of the total segment revenue.

PCS Segment Analysis

In the PCS segment, CompuGroup Medical SE & Co. KGaA faced a slight decrease in revenue in the first quarter of 2024, down 2% year-over-year to EUR 34 million, influenced by one-time hardware sales in Italy. However, recurring revenues increased by 6% to EUR 25 million, making up 72% of the segment's total revenues.

Summarized from source with an LLMView Source

Key figures

-58.8%1Y
-80.3%3Y
%5Y

Performance

80.7%1Y
89.3%3Y
93.8%5Y

Volatility

Market cap

755 M

Market cap (USD)

Daily traded volume (Shares)

700

Daily traded volume (Shares)

1 day high/low

14 / 14

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Alten
Alten Alten Valor: 991814
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.37%EUR 77.70
Soitec SA
Soitec SA Soitec SA Valor: 35180513
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.48%EUR 68.25
UBISOFT Entertainment
UBISOFT Entertainment UBISOFT Entertainment Valor: 491199
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.52%EUR 12.48
Planisware
Planisware Planisware Valor: 134585679
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.52%EUR 22.14
Wavestone SA
Wavestone SA Wavestone SA Valor: 43511250
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.34%EUR 45.40
Vetoquinol SA
Vetoquinol SA Vetoquinol SA Valor: 1393361
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.76%EUR 78.30
Celestica Inc
Celestica Inc Celestica Inc Valor: 134408382
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.13%USD 91.44
Prosus N.V.
Prosus N.V. Prosus N.V. Valor: 49729630
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%EUR 38.10
ASM International NV
ASM International NV ASM International NV Valor: 538608
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.16%EUR 496.40
BE Semiconductor Industries NV BESI
BE Semiconductor Industries NV BESI BE Semiconductor Industries NV BESI Valor: 41641428
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.37%EUR 107.50